Zardugal

[Flip]

ZARDUGAL WILL TAKE AWAY THE PAIN
Why analgetics "made in Zardugal" might flood the international market soon




After scientists of the Institute of Botanical Genetics published their results about the genetic modification of Papaver bracteatum, both chemical industry and government economists saw an opportunity. The GMO-crop which is not only more robust but even more profitable than its naturally occuring cousin holds the potential of producing amounts of morphine and morphine-derivatives exceeding domestic demands many times. An abuse of the designed variation is not expected, due to the accumulated secondary compound being the inactive biochemical progenitor Thebaine rather than Morphine, which is acquired later on through steps of chemical processing.

ZARD-Algetico, a newly founded, state owned pharma-company was provided funds by the Commissariat of Trade and Industry and, in collaboration with scientists of the Institute for Pharmaceutical Chemisty, entrusted with the task of locating promising areas for poppy-plantations as well as laying out plans for chemical synthesis plants. Parts of the necessary equipment and infrastructure can be acquired by dismantling unprofitable fertilizer and metallurgy plants currently owned by the state through application of LDRE, while other parts will be constructed from scratch or imported if needed.